July 18, 2024

Political Commentary

News Politics Business Sports

RayzeBio Stock Surges 101% on $4.1 Billion Takeover by Bristol Myers

1 min read

Bristol Myers Squibb will acquire radiopharmaceutical therapeutics company RayzeBio for $62.50 a share in cash.

Continue reading this article with a Barron’s subscription.

View Options

2023-12-26 11:19:00

All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator

Read more from original source here…

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.